Immunotherapy for secondary glioblastoma multiforme: toward an isocitrate dehydrogenase vaccine. World Neurosurg 2014 Dec;82(6):933-5
Date
10/15/2014Pubmed ID
25311977DOI
10.1016/j.wneu.2014.10.006Scopus ID
2-s2.0-84927565296 (requires institutional sign-in at Scopus site) 2 CitationsAuthor List
Abecassis IJ, Morton RP, Nerva JD, Kim LJAuthor
John D. Nerva MD Assistant Professor in the Neurosurgery department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AnimalsCancer Vaccines
Female
Glioma
Humans
Isocitrate Dehydrogenase
Male
Mutant Proteins